Acarbose--an effective drug for the prevention of type 2 diabetes and cardiovascular diseases?
Laakso, M.
Duodecim; Laaketieteellinen Aikakauskirja 119(20): 1921-1923
2003
ISSN/ISBN: 0012-7183 PMID: 14639996 Document Number: 560212
Document emailed within 1 workday
Related Documents
Breuer, H.W.M. 2003: Review of acarbose therapeutic strategies in the long-term treatment and in the prevention of type 2 diabetes International journal of clinical pharmacology and therapeutics 41(10): 421-440Mosseri, M.M.; Fisman, E.Z.; Tenenbaum, A. 2006: Type 2 diabetes mellitus and cardiovascular diseases: evaluation, treatment and prevention strategies Harefuah 145(2): 141-6 164
2001: Type 2 diabetes. Acarbose interrupts the vicious circle MMW Fortschritte der Medizin 143(14): 46-47
Birkeland, K.I.; Claudi, T.; Hansteen, V.; Hanssen, K.F.; Hjermann, I.; Jenssen, T.; Jervell, J.; Os, I. 2000: Prevention of cardiovascular disease in type 2 diabetes Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(21): 2554-2559
Windler, E. 2003: Acarbose for prevention of diabetes mellitus. STOP-NIDDM] Der Internist 44(4): 491-493
González Sarmiento, E.; Ergueta Martín, P.; Fernández Martínez, I.; Hinojosa Mena-Bernal, M.C.; Zurro Muñoz, I.; Zurro Hernández, J. 2001: Changes in metabolic parameters and microalbuminuria in patients with type 2 diabetes treated with acarbose Anales de Medicina Interna 18(5): 234-236
Sailer, D.; Gossner, L.; Schönfuss, I. 1992: Effect of acarbose on injection-eating interval in type i diabetes. Preliminary contribution Fortschritte der Medizin 110(26): 479-480
Juntti-Berggren, L.; Pigon, J.; Hellström, P.; Holst, J.J.; Efendic, S. 2000: Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes Diabetes Nutrition and Metabolism 13(1): 7-12
Mughal, M.A.; Memon, M.Y.; Zardari, M.K.; Tanwani, R.K.; Ali, M. 2000: Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes Jpma. Journal of the Pakistan Medical Association 50(5): 152-156
Krupej, J.; Kedzierski, L.; Gdula-Dymek, A.; Krysiak, R.; Okopień, B.ła. 2011: Beta-adrenolitics in therapy of cardiovascular diseases in patients with type 2 diabetes mellitus Wiadomosci Lekarskie 64(2): 132-141
Soonthornpun, S.; Rattarasarn, C.; Thamprasit, A.; Leetanaporn, K. 1998: Effect of acarbose in treatment of type Ii diabetes mellitus: a double-blind, crossover, placebo-controlled trial Journal of the Medical Association of Thailand 81(3): 195-200
Wang, R.R.; Lv, Z.M.; Dan, Y.P.; Chen, K.Y.; Zhang, C. 2019: Effects of acarbose and siglitine on blood glucose fluctuation and islet β-cell function in patients with type 2 diabetes mellitus Journal of Biological Regulators and Homeostatic Agents 33(2): 365-374
Tuomilehto, J.; Lindström, J. 2003: The principal trials for prevention of type 2 diabetes have now confirmed that type 2 diabetes can be prevented by life style changes. Prevention of type 2 diabetes by life style Journees Annuelles de Diabetologie de l'Hotel-Dieu 2003: 77-89
1999: Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases: The Role of the Cardiovascular Specialist Canadian Journal of Cardiology 15 Suppl G: 1g
Jarrett, R.J. 2001: Glycaemia and vascular effects of type 2 diabetes. Relation between diabetes and hyperglycaemia and cardiovascular disease has not been resolved Bmj 322(7296): 1246-1247
Makar, O.; Siabrenko, G. 2018: Influence of Physical Activity on Cardiovascular System and Prevention of Cardiovascular Diseases (Review) Georgian Medical News 2018(285): 69-74
Chopeĭ, I.V.; Rosul, M.M.; Hechko, M.M.; Chubirko, K.I.; Korabel'shchykova, M.O.; Ivan'o, N.V. 2014: Cardiovascular continuum: the role of the family doctor in prevention of cardiovascular diseases Wiadomosci Lekarskie 67(2 Pt 2): 243-247
Del Prato, S.; Felton, A.-M.; Munro, N.; Nesto, R.; Zimmet, P.; Zinman, B. 2007: Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Recommendations from the Global Partnership for Effective Diabetes Management International Journal of Clinical Practice. Suppl 157: 47-57
Lindström, J.; Neumann, A.; Sheppard, K.E.; Gilis-Januszewska, A.; Greaves, C.J.; Handke, U.; Pajunen, P.; Puhl, S.; Pölönen, A.; Rissanen, A.; Roden, M.; Stemper, T.; Telle-Hjellset, V.; Tuomilehto, J.; Velickiene, D.; Schwarz, P.E.; Acosta, T.; Adler, M.; AlKerwi, A.; Barengo, N.; Barengo, R.; Boavida, J.M.; Charlesworth, K.; Christov, V.; Claussen, B.; Cos, X.; Cosson, E.; Deceukelier, S.; Dimitrijevic-Sreckovic, V.; Djordjevic, P.; Evans, P.; Felton, A-M.; Fischer, M.; Gabriel-Sanchez, R.; Gilis-Januszewska, A.; Goldfracht, M.; Gomez, J.L.; Greaves, C.J.; Hall, M.; Handke, U.; Hauner, H.; Herbst, J.; Hermanns, N.; Herrebrugh, L.; Huber, C.; Hühmer, U.; Huttunen, J.; Jotic, A.; Kamenov, Z.; Karadeniz, S.; Katsilambros, N.; Khalangot, 2010: Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe Hormone and Metabolic Research 42 Suppl. 1: S37-S55
Majeed, A.; Newnham, A.; Ryan, R.; Khunti, K. 2002: Prevention and cure of type 2 diabetes. General practitioners are treating more cases of diabetes Bmj 325(7370): 965